Companies To Watch
-
Companies To Watch: OSE Immunotherapeutics
4/22/2024
OSE Immunotherapeutics is poised to begin a confirmatory and pivotal Phase 3 trial for a novel cancer vaccine targeting the second line in NSCLC, an area of acute unmet need.
-
Companies To Watch: Antiva Biosciences
2/27/2024
Antiva Biosciences is exploring a local and global opportunity with a topically administered HPV treatment.
-
Companies to Watch: Promontory Therapeutics
2/1/2024
A novel small molecule developer aims to shake up the solid tumor treatment landscape.
-
Companies To Watch: KeifeRx
1/1/2024
Founded in late 2019, KeifeRx is repurposing oncology drugs for neurodegenerative disorders.
-
Companies To Watch: Freya Biosciences
11/1/2023
Freya Biosciences is enlivening the long-time lonely space of reproductive health, starting with a new focus on the vaginal microbiome.
-
Companies To Watch: Spruce Biosciences
10/2/2023
Spruce Biosciences is currently in mid-to-late stage clinical development of new agents to treat rare endocrine disorders.
-
Companies To Watch: Nido Biosciences
9/1/2023
See why Nido Biosciences is developing small molecule drugs for rare neurodegenerative diseases.
-
Companies To Watch: Ventoux Biosciences
8/1/2023
Why Ventoux Biosciences is pursuing drug treatments for all sufferers of Dupuytren’s and other fibroproliferative diseases.
-
Companies To Watch: Kinaset Therapeutics
7/3/2023
Kinaset Therapeutics is moving fast in the respiratory space to advance a potential first-time therapy.
-
Companies To Watch: Orca Bio
6/1/2023
Orca Bio is creating a new cell therapy aimed at bringing rebirth to stem-cell transplantation.